Crossmark

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?

Published Online: 2020-08-11

Published Print: 2020-08

Authors

van der Stuijt, W.

Quast, A. B. E.

Knops, R. E.
License Information

Text and Data Mining valid from 2020-08-01

Version of Record valid from 2020-08-11
More Information

Article History

First Online: 11 August 2020

Conflict of interest

: W. van der Stuijt and A.B.E. Quast have nothing to disclose. R.E. Knops reports consultancy fees and research grants from Abbott, Boston Scientific, Cairdac and Medtronic, as well as stock options from AtaCor Medical Inc.

Document is current